FDA Inspection 1217918 — Carter BloodCare
The FDA completed an inspection of Carter BloodCare on Aug 22, 2023 in Bedford, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bedford, TX (United States)